HIV disclosure is defined as revealing one's HIV status to other persons (Adejumo, 2011) . Increased HIV disclosure is generally associated with reduced HIV transmission and better mental health (Chaudoir, Fisher, & Simoni, 2011) . Despite the importance of increasing HIV disclosure for both persons living with HIV (PLHIV) and sero-negative individuals, estimated HIV disclosure rates among PLHIV remain alarmingly low in the United States (52-59%; Sullivan, 2009) and across international settings (see Obermeyer & Osborn, 2007; Ssali et al., 2010) .
One construct shown to be related to HIV disclosure is HIV-related stigma (Brent, 2016) . Stigma is a multifaceted construct referring to one's social identity (Goffman, 1963; Herek, 2014; Nyblade, 2006) . HIVrelated stigma is a global (i.e., higher-ordered, overarching) factor theorized as a combination of four distinct sub-factors including (1) negative self-imagefeeling inferior, shameful, or guilty; (2) enacted stigmaexperiences of rejection or discrimination in the past; (3) concerns with public attitudessubjective beliefs regarding how others view PLHIV; and (4) disclosure concerns -perceptions that one's HIV status needs to be concealed (Bunn, Solomon, Miller, & Forehand, 2007) . Each of these stigma sub-factors have been inversely related to HIV-status disclosure (Brent, 2016; Catona, Greene, Magsamen-Conrad, & Carpenter, 2016; Elopre et al., 2016; Rwemisisi, Wolff, Coutinho, Grosskurth, & Whitworth, 2008) . Further, the negative association between HIV-related stigma and HIV disclosure is evident across various cultures and age ranges (DeAlmeida, 2009; Emlet, 2006 ). Yet, despite consistent evidence that HIV-related stigma is related to HIV disclosure (French, Greeff, Watson, & Doak, 2015; Obermeyer, Baijal, & Pegurri, 2011; Steward et al., 2008) , there remains a need to explicate moderators of this relation to better identify individuals "at-risk" for non-disclosure.
One factor potentially impacting HIV-related stigma and HIV disclosure is emotion dysregulation. Emotion dysregulation encompasses deficiencies in one's awareness, understanding, and modulation of affective arousal (Gross, 1998; Gross & Jazaieri, 2014) . Among PLHIV, emotion dysregulation has been shown to mediate the relations between perceived distress tolerance and anxiety/depressive symptoms, such that the relations between distress tolerance and anxious/depressive symptom severities were better explained via emotion regulation difficulties (Brandt, Gonzalez, Grover, & Zvolensky, 2013) . Other work has found higher emotion dysregulation in conjunction with greater depressive symptoms is associated with greater severity of HIVrelated symptoms, greater likelihood of avoidant coping strategies, poorer HIV medication adherence, and lower tolerance of distress (Brandt, Bakhshaie, Zvolensky, Grover, & Gonzalez, 2015) .
Interestingly, emotion dysregulation has not been explored in relation to HIV-related stigma and HIV disclosure among PLHIV. Although HIV disclosure is not universally related to positive outcomes (Gielen et al., 2000; Pachankis, 2007) , emotion dysregulation may be associated with less disclosure, thereby serving to maintain unhealthy mental health outcomes. As an (theoretical) example, an HIV+ individual with greater emotion regulation difficulties may be more reactive when experiencing stigmatization (e.g., discrimination, violence) relative to an HIV+ individual with lower levels of emotion dysregulation. Accordingly, the emotionally dysregulated HIV+ individual may be less likely to risk encountering consequential reactions of others via disclosure, and in turn, perpetuating and/or amplifying their own emotional distress.
Together, the current study examined whether emotion dysregulation moderated the associations between HIVrelated stigma and HIV disclosure among PLHIV. It was hypothesized that greater levels of emotion dysregulation with concurrently high levels of HIV-related stigmaas a global index and across all stigma sub-factorswould be associated with lower rates of HIV disclosure. Further, as HIV-related stigma has been shown to be multifaceted (Bunn et al., 2007) , we planned follow-up analyses examining associations between each stigma sub-factor and disclosure and the moderating role of emotion dysregulation across each of the proposed models ( Figure 1 ).
Method
Participants Participants in the current study included 80 adults with a self-reported diagnosis of HIV/AIDS (61.2% male, 37.5% female, 1.3% transgender; M age = 48.25, SD = 7.39). The sample was recruited from an urban area located in southwestern Texas and was ethnically diverse (32.5% White/Caucasian, 56.2% Black/Non-Hispanic, 5% Black/Hispanic, 3.8% Hispanic, and 2.5% "Mixed/ Other"). Approximately 66% of participants reported obtaining a high school degree or completing "some college" as their highest level of education. The majority (78.8%) of our sample reported being currently unemployed, with over half (58.8%) having an annual income of $10,000 or less. Nearly half (48.7%) of the sample identified as heterosexual, 32.5% as homosexual, 16.3% as bisexual, and 2.5% identifying as transgendered. Regarding HIV status, 43.8% of participants reported a diagnosis of HIV, 48.7% reported a diagnosis of AIDS, while 7.5% did not know their status. On average, participants within our sample reported living with an HIV diagnosis for 17 years (SD = 8.43). Further, participants reported an average CD4 T-cell count of 573.25 (SD = 283.1), ranging from 28 to 1300, and 71.1% reported an undetectable viral load. Eighty-five percent of our sample met criteria for having a psychological disorder (for specific diagnostic prevalence rates see Table 1 ). There was also a high rate of comorbidity within our sample (M diagnoses = 2.36, SD = 1.98), with 53.7% meeting criteria for multiple disorders.
Individuals deemed eligible for participation were between the ages of 18 and 65, had a positive diagnosis of HIV/AIDS, and capable of providing informed written consent. Participants were excluded from study participation if they were unable to provide informed consent, could not answer questions accurately due to illiteracy, or could not reliably attend scheduled appointments. Five participants were not included in analyses due to insufficient completion of key measures or random response patterns.
Procedure
For the current study, cross-sectional baseline data was taken from a larger project examining the effectiveness of an anxiety-reduction program developed for PLHIV (F31 MH099922). Potential participants responded to flyers posted at local HIV/AIDS Service Organizations. Interested individuals contacted research staff and were screened for eligibility via phone, and if deemed eligible, were scheduled for a baseline appointment. Upon completion of the appointment, participants were compensated with a $20 gift card to a regional grocery store. The University of Houston's Institutional Review Board approved all study procedures.
Measures
MINI International Neuropsychiatric Interview (MINI; Lecrubier et al., 1997) . The MINI is a semi-structured diagnostic interview developed to assess a wide range of psychological disorders (emotional disorders, substance use disorders, psychosis, etc.). The MINI used in the current study evaluated all symptoms endorsed by participants based on disorder criteria from the DSM-IV. The diagnostic interview specifically assessed current diagnoseslifetime diagnoses were only considered if clinically relevant to the present diagnosis (e.g., recurrent major depressive disorder). The MINI has been utilized in prior studies examining HIV+ samples (e.g., Breuer et al., 2014) and is psychometrically sound (see Lecrubier et al., 1997 ). In the current study, 12.5% of MINI diagnostic interviews were checked for reliability by a trained doctoral-level rater; no discrepancies were noted.
HIV/AIDS Stigma Scale (HASS). The HASS (Bunn et al., 2007 ) is a self-report assessment of HIV/AIDSrelated stigma. The HASS comprises of 32 items on a Likert-type scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). The HASS measures global HIV-related stigma via the aggregate of four sub-types of stigma including: Enacted Stigma (HASS-E), Public Attitudes (HASS-P), Negative Self-Image (HASS-N), and Disclosure Concerns (HASS-D). The HASS-E subscale assesses personal experiences of rejection in the past. The HASS-N subscale pertains to internalized concerns such as feelings of shame or guilt. The HASS-P subscale measures the infected person's beliefs of what other people think about PLHIV. HASS-D is related to perceived obligations to hide one's HIV status from others. The HASS has demonstrated strong psychometric properties (Bunn et al., 2007) . In the current study, internal consistency values for the HASS subscales ranged from adequate (α = .76) to excellent (α = .94). Difficulties in Emotion Regulation Scale (DERS). The DERS (Gratz & Roemer, 2004 ) is a multidimensional self-report measure used to assess global emotion dysregulation as well as a variety of emotion dysregulation sub-facets. The DERS consists of 36 items on a 5-point Likert-type scale 1 ("almost never") to 5 ("almost always"). Domains of affect regulation assessed include: non-acceptance of emotional responses, limited access to emotion regulation strategies, difficulties in engaging in goal-directed behaviors, impulse control difficulties, lack of emotional awareness, and lack of emotional clarity. Higher scores on these dimensions indicate greater degrees of difficulty. For the current study, the global emotion dysregulation composite was utilized (α = 0.95).
Positive and Negative Affect Schedule (PANAS). The PANAS (Watson, Clark, & Tellegen, 1988 ) is a widely used self-report measure consisting of 20 items measuring trait negative and positive emotional states, as measured by positive affect (PA) and negative affect (NA) subscales. The PANAS was developed such that these two subscales can be used as independent measures, depending on the affective-valence of interest. Past studies indicate the psychometric properties of the PANAS are acceptable in both anxious and depressive samples (Brown, Chorpita, & Barlow, 1998; Watson, Clark, & Carey, 1988) , as well as HIV+ samples (e.g., Gonzalez, Zvolensky, Solomon, & Miller, 2010) . Trait rather than state instructions for the negative affect subscale (PANAS-NA) were used and the internal consistency in the current sample was good (α = .87).
HIV disclosure status. Disclosure status was determined via self-report. Specifically, participants were asked how many people to whom they have disclosed their HIV status. This item indexed good variability (R 2 = 0.873), with 1.3% reporting "nobody", 16.3% reporting "hardly anybody", 36.3% reporting "a few people", 35% reporting "almost anyone", and 11.3% reporting "everyone".
Analytic strategy
Using SPSS 22.0, bivariate correlations among study variables were examined and moderation tests were conducted using hierarchical linear regression. In hierarchical regression-based moderation models, the unstandardized regression coefficients are estimated for associations between HIV-related stigma (HASS total; X ) and emotion dysregulation (DERS; Z ) with the outcome (HIV disclosure; Y ) while setting the other equal to zero. Both the X and Z were mean-centered. For each model, study covariates (age, race, gender, sexual orientation, education, and negative affect) were entered in step 1 of a hierarchical linear regression, followed by the mean-centered values for X and Z in step 2, and the interaction variable (i.e., the product of the meancentered X and Z variables) in step 3. To probe the interaction, regions of significance were determined using the Johnson-Neyman (J-N) technique (Bauer & Curran, 2005) , calculated by the PROCESS macro (Hayes, 2013) . In contrast to other interaction probing methods, the J-N technique estimates exact values of Z which yield the critical value used to determine statistical significance (Bauer & Curran, 2005) .
Results

Descriptive data and bivariate relations
For bivariate correlations of all variables, see Table 2 . HIV disclosure was significantly negatively associated with HASS total (r = −.39, p < .001) and all four HASS subscales (r's < −.26, p's < .03) but not DERS (r = −.10, p = .371). HASS subscales were significantly positively correlated with each other (r's > .55, p's < .001). With the exception of HASS-D (r = .17, p = .127), HASS subscales were significantly positively associated with DERS (r's > .30, p's < .006).
Moderation analyses: stigma total score
As a set, covariates entered in the first step did not account for a significant amount of variance in HIV disclosure (R 2 = .07, F(6, 73) = 0.88, p = .516; Table 3 ). Emotion dysregulation was not significantly associated with disclosure (β = .03, t = 0.16, p = .872), whereas and the global index of HIV-related stigma (HASS Total) was significantly and negatively associated with disclosure (β = −.42, t = −3.56, p < .001; Table 3 ). Contrary to hypotheses, there was not a significant interaction of emotion dysregulation and HIV-related stigma (β = −1.10, t = −1.63, p = .108). However, post-hoc examination of the pattern of findings using the J-N revealed a trend consistent with hypotheses. Specifically, increased HIV-related stigma was significantly associated with reduced disclosure for those with greater emotion dysregulation (DERS ≥ 71.7), which applied to 77.5% of the sample (see Figure 2 , top left), but not to those with less emotion dysregulation.
Moderation analyses: stigma sub-factors
Due to the multifaceted nature of HIV-related stigma, separate analyses were conducted with each of HASS sub-factors as the X variable, moderated by emotion dysregulation (Figure 1) . In the first model, which examined the associations of enacted stigma (HASS-E) and emotion dysregulation on HIV disclosure, emotion dysregulation was not significantly associated with disclosure (β = .01, t = 0.04, p = .968; Table 3 ). HASS-E, however, was significantly related to lowered disclosure (β = −.25, t = −2.01, p = .049). Further, there was a significant interaction between emotion dysregulation and enacted stigma (β = −1.46, t = −2.34, p = .022); post-hoc analyses using the J-N technique were used as recommended by Hayes (2013) . Results indicated the stigma-disclosure association was only significant when emotion dysregulation scores were ≥ 92.3 (42.5% of the current sample; Figure 2 top right), indicating that as emotion dysregulation scores increase, the association of HASS-E with disclosure becomes significant, and increases in strength with greater emotion dysregulation.
In the public attitudes model (HASS-P), emotion dysregulation was not significantly associated with disclosure (β = −.04, t = −0.23, p = .816; Table 3 ), whereas HASS-P was significantly associated with disclosure (β = −.29, t = −2.37, p = .020), indicating that HASS-P and disclosure are inversely related. There was a significant interaction between emotion dysregulation and public attitudes (β = −1.24, t = −2.06, p = .043). The J-N technique revealed that the association of HASS-P with disclosure is only significant when emotion dysregulation scores are ≥84.0 (60.0% of current sample; Figure 2 bottom left), indicating that the association between HASS-P and HIV disclosure is significant only for those with greater emotion dysregulation, with the strength of the association increasing as emotion dysregulation increased. Surprisingly, in the negative self-image model (HASS-N), emotion dysregulation was not significantly associated with disclosure (β = .05, t = 0.32, p = .752; Table 3) whereas HASS-N yielded statistical significance (β = −.39, t = −3.01, p = .004). There was not a statistically significant interaction between emotion dysregulation and HASS-N (β = −1.04, t = −1.58, p = .118). However, examination of the J-N test of significant regions revealed a similar pattern of results, such that HASS-N was significantly associated with disclosure when emotion dysregulation scores are high (≥ 72.4, which includes 77.5% of current sample; see Figure 2 bottom right).
Finally, disclosure concerns (HASS-D) was significantly associated with status disclosure (β = −.52, t = −5.16, p < .001). Yet, when considering HASS-D, emotion dysregulation was not significantly associated with status disclosure (β = −.08, t = −0.57, p = .572; Table 3 ). No significant interaction was evident (β = .15, t = 0.26, p = .796). Additionally, the J-N technique Table 2 . Means, standard deviations and bivariate correlations among variables (n = 80). (Bunn et al., 2007) ; DERS: difficulties in emotion regulation scale (Gratz & Roemer, 2004 provided no evidence of a moderating role of emotion dysregulation (i.e., HASS-D scores were associated with disclosure at nearly every value of emotion dysregulation).
Discussion
Results were partially consistent with predictions. Specifically, there were statistically significant interactions between emotion dysregulation and enacted stigma and perceptions of public attitudes. The observed significant interactions were evident above and beyond the variance accounted for by the main associations of stigma and emotion dysregulation, as well as an array of covariates (e.g., gender, race, sexual orientation, negative affectivity). The pattern of significant interactions indicated that greater levels of stigma were associated with reduced rates of HIV disclosure only for those with greater emotion dysregulation. The present results suggest that greater emotion dysregulation may exacerbate the associations of HIV-related enacted and/or public attitude stigma among PLHIV. Conversely, greater emotion regulation may serve as a protective factor against these associations, buffering PLHIV against the negative impact of HIV-related enacted and public attitude stigma. Future work could usefully examine whether psychotherapies targeting emotion regulation can help buffer PLHIV from such stressors, and whether such interventions can improve behaviors relevant to public health, such as disclosure of HIV status. Contrary to our prediction, there were no significant interactions for emotion dysregulation and the composite index HIV stigma, as well as two of the sub-factors: negative self-image, and disclosure concerns. However, the pattern of findings (based on the J-N procedure) in all cases was conceptually similar to those obtained for the enacted and public attitude stigma. Thus, greater HIV-related stigma was associated with lower disclosure, and this association was dependent upon greater levels of emotion dysregulation. Yet, there was no evidence of a moderating role of emotion dysregulation in terms of HIV-related stigma and disclosure. In the case of stigma related to disclosure concerns, HIV disclosure and HIV disclosure concerns had more shared variance (28%) compared to the other three HASS sub-factors (shared variance ranged from 6.8%-10.2%). Thus, it is possible that the overlapping constructs prevented additional variance to be explained by emotion dysregulation and/or the interaction term. Moreover, statistical power due to the present sample size may have impacted the ability to isolate the interaction.
Although not primary study aims, a number of observations warrant brief comment. First, the sub-factors of HIV-related stigma and emotion dysregulation were differentially related to HIV disclosure. Specifically, enacted stigma, public concerns, negative self-image and disclosure concerns were significantly negatively related to disclosure (range of β's = −.26 to −.53). Second, there was no evidence that emotion dysregulation was significantly related to the dependent measure. Future research could usefully explore whether distinct aspects of emotion dysregulation (e.g., emotional awareness vs. non-acceptance) play differential roles in relation to HIV disclosure.
There are some study limitations. First, the cross-sectional design of the present study does not permit inferences regarding causality. Therefore, future investigations could build upon the present work and aim to test these relations by utilizing a longitudinal design. Second, our study utilized a small sample size, potentially reducing power. Thus, future work could replicate and extend the present results with larger sample sizes. Third, the current study's data were collected solely from individuals seeking treatment. Accordingly, disclosure rates in the current study may be inflated relative to the general HIV+ population (Medley, Garcia-Moreno, McGill, & Maman, 2004; Obermeyer et al., 2011; Sullivan, 2009 ). Fourth, temporal factors (i.e., length of time from initial seropositive diagnosis) should be considered in future research (Mansergh, , & Simoni, 1995) . Fifth, due to the monomethod measurement approach, method variance may influence the current findings. Thus, future work should consider multimethod assessment to index the primary independent and dependent variables. Lastly, the observed associations were generally small in size (Beta values .01-.11); examination of other factors that impact these relations may help to explain additional variance.
Marks
Together, the present study suggests emotion dysregulation may moderate the associations of stigma on disclosure for individuals experiencing enacted stigma and concerns regarding public attitudes towards PLHIV. Although future work is needed to further understand the nature of these relations, the present study provides novel empirical evidence regarding the mechanistic processes by which HIV-related stigma may deter disclosure of HIV status. Findings may have beneficial implications for current HIV treatment/prevention strategies in regard to reducing HIV-related transmission behavior among PLHIV.
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